Friday, November 26, 2021

Merck Says Its Covid Pill Is Less Effective in a Final Analysis

The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.

from NYT > Top Stories https://ift.tt/3p2BTlU
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Can NASA Really Land Astronauts on the Moon by 2028?

Experts have been hopeful, but say the agency’s lunar aspirations are largely at the whims of two billionaires, Elon Musk and Jeff Bezos. ...